ArticleOncotarget2017

miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.

Huining Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.